ResearcherOsaka International Cancer InstituteActive in the last 2 years
Yoshiyuki Fujiwara
Matched on OpenAlex author ID A5106184419. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 15
2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 3
- Impact of CD73+CD39+ B Cells on Immune Evasion in Pancreatic Cancer. Last author DOI 10.21873/anticanres.18437↗
- Correlation between relative dose intensity of adjuvant S-1 chemotherapy and psoas muscle mass volume and survival after resection of pancreatic ductal adenoca… Last author DOI 10.1097/md.0000000000038292↗
- Preoperative gemcitabine-based chemoradiation therapy for pancreatic ductal adenocarcinoma of the body and tail: impact of splenic vessels involvement on opera… Co-author DOI 10.1016/j.surg.2014.09.022↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Mikiya Kishino · 2 shared papers, 2024–2026 · strength 0.43
- Teruhisa Sakamoto · 2 shared papers, 2024–2026 · strength 0.43
- Masaki Morimoto · 1 shared paper, 2026 · strength 0.23
- Takuki Yagyu · 1 shared paper, 2026 · strength 0.23
- Yoshihisa Umekita · 1 shared paper, 2026 · strength 0.23
- Yuki Murakami · 1 shared paper, 2024 · strength 0.20
- Takehiko Hanaki · 1 shared paper, 2024 · strength 0.20
- Masahiko Yano · 1 shared paper, 2015 · strength 0.04
- Hiroaki Ohigashi · 1 shared paper, 2015 · strength 0.04
- Masato Sakon · 1 shared paper, 2015 · strength 0.04
- Hirofumi Akita · 1 shared paper, 2015 · strength 0.04
- Shigeru Marubashi · 1 shared paper, 2015 · strength 0.04
- Kunihito Gotoh · 1 shared paper, 2015 · strength 0.04
- Osamu Ishikawa · 1 shared paper, 2015 · strength 0.04
- Hidenori Takahashi · 1 shared paper, 2015 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.